Project Grant SB1HL176360
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$500K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research Program (CFDA 93.837) to Steth X Microsystems Inc. The funding supports the development of a smart, wearable contact microphone patch for extended and remote monitoring of lung functions, with a focus on respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The wearable device aims to accurately detect and quantify adventitious lung...
This $1,052,276 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development and validation of a wearable multimodal sensor system for remote monitoring of patients with chronic obstructive pulmonary disease (COPD). The project, titled "Bilateral Acoustic Sensing and Automated Breathing Segmentation for Remote Monitoring of Patients with COPD: A Longitudinal Study," aims to...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $333,810 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Novis Products, LLC in Gainesville, FL. The grant supports the development of the RMT Complete, an all-in-one respiratory muscle training device and mobile application. The RMT Complete aims to enhance breathing function and quality of life for patients with chronic obstructive pulmonary disease (COPD) by combining features such as an...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,160,157 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Liberandum Technologies, Inc. in San Francisco, CA. The goal of this Phase I Small Business Innovation Research (SBIR) project is to develop and test a bidirectional synchronous flow-controlled ventilation system to improve oxygenation and ventilation in patients with acute respiratory distress syndrome (ARDS). The ventilation system aims to provide gentle...
The National Heart, Lung, and Blood Institute (NHLBI), through its Cardiovascular Diseases Research Program (CFDA 93.837), awarded a $400,000 Project Grant to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The grant supports the development of an advanced analytical testing device to quantitatively characterize lipoprotein particles in blood. Lipoproteins are key indicators of cardiovascular disease risk, as certain classes can contribute to the buildup...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $863,328 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Aquillius Corp, a small disadvantaged women-owned business located in San Diego, CA. The grant supports the development of a wearable graphene respiratory sensor for early detection and continuous monitoring of asthma, particularly in children. The project aims to optimize the sensor's...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $790,738 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Circulatech LLC. The funding will support the development and testing of the Thoraflush, a proactive clot-preventing cardiac chest tube that utilizes dual irrigation technology to maintain drainage patency. The goals of the project are to: 1) optimize the Thoraflush's efficacy in a...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $1,013,000 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Endolynx Inc. to develop an Optical Sensor-Enabled Endotracheal Tube (OS-ETT). The OS-ETT aims to reduce the risks and incidence of esophageal intubation and unintended extubation, which collectively result in over $12 billion in unnecessary costs annually in the U.S. The OS-ETT's optical sensors,...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), awarded a 5-year $807,067 Project Grant to the University of Virginia to pioneer the quantitative documentation of the human respiratory kinematic profile. The project aims to identify novel respiratory kinematic physiomarkers that can improve the prediction of severe respiratory failure beyond conventional monitoring. Key activities include recording the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), focuses on developing and demonstrating a high-volume manufacturing technology for microfluidic oxygenators. The goal is to enable safer, simpler treatment of respiratory failure through extracorporeal membrane oxygenation (ECMO) therapy. The $294,063 award to Biomembretics, Inc. will fund a two-phase project to: 1) define the target...